Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...
主要な著者: | Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2019
|
類似資料
-
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
著者:: Donovan, JL, 等
出版事項: (2017) -
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
著者:: J. Donovan, 等
出版事項: (2003-01-01) -
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
著者:: S. Sanghera, 等
出版事項: (2020-10-01) -
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
著者:: Young, GJ, 等
出版事項: (2017) -
Addressing patient treatment preferences at trial recruitment.
著者:: Mills, N, 等
出版事項: (2011)